Cognitive Longevity Protocol

Protocol overview

Cognitive decline is not inevitable. The research on dementia prevention is now substantial enough to act on: sleep quality may be the single most important factor (the glymphatic system clears amyloid only during sleep), while aerobic exercise reliably grows the hippocampus and maintains BDNF levels. This protocol weights every choice toward brain protection.

Time commitment: 7–9 hours. Complexity: Intermediate. Cost level: Moderate.

Who this is for

Anyone with family history of dementia, cognitive concerns, or who prioritizes mental sharpness and neuroprotection above all other longevity goals.

Core principles

• Sleep is the #1 priority: 7–9 hours is when the glymphatic system clears amyloid-beta and tau from the brain
• Aerobic exercise (particularly Zone 2) reliably increases BDNF and hippocampal neurogenesis in humans
• DHA omega-3 is the most brain-concentrated fatty acid — maintaining high serum DHA is neuroprotective
• Mediterranean and MIND diets are associated with reduced Alzheimer's risk across multiple cohorts; the 2025 US POINTER trial confirmed structured multidomain lifestyle intervention (diet + exercise + cognitive training + cardiometabolic monitoring) slows cognitive decline in at-risk older adults — extending the earlier Finnish FINGER findings
• Chronic stress and elevated cortisol are direct drivers of hippocampal atrophy — stress management is protocol, not optional
• Social connection and cognitive challenge (learning new skills) independently predict dementia outcomes
• Hearing loss is the largest modifiable midlife dementia risk factor (Lancet Commission 2024) — hearing aids when needed are a high-leverage neuroprotective intervention

Interventions from the rankings

• 7-9 hours quality sleep
• 150+ min Zone 2 cardio weekly
• Resistance training 2-3x/week
• Mediterranean diet
• Sauna 4x/week

Supplement stack

• Omega-3 (High-DHA Formula) — 2g+ DHA specifically (not just combined EPA+DHA) daily: DHA is the dominant fatty acid in neuronal membranes. The brain is 60% fat, predominantly DHA. Low DHA is consistently associated with faster cognitive decline. Look for formulas with high DHA:EPA ratio.
• Lion's Mane Mushroom — 1,000–3,000mg standardized extract daily: Stimulates nerve growth factor (NGF) synthesis in vitro. The often-cited Mori 2009 Japanese RCT in mild cognitive impairment was small (n≈30); a 2023 systematic review found cognitive effects in healthy adults inconsistent. Promising mechanism, modest human evidence — included as a low-risk addition rather than a high-confidence intervention.
• Magnesium L-Threonate — 1,500–2,000mg (providing ~144mg elemental Mg) daily: The only magnesium form preclinically shown to raise brain magnesium across the blood-brain barrier (Slutsky 2010). Small human pilot trials (Liu 2016, Wroolie 2017) suggest cognitive and subjective sleep benefits but are underpowered. Mechanism is strong; large definitive RCTs are still lacking — reasonable to use specifically when brain-targeted Mg is the goal.
• Bacopa Monnieri — 300–600mg standardized extract (45% bacosides) daily: Among the best-studied nootropics with multiple RCTs showing improvements in memory formation, recall speed, and anxiety reduction. Works best after 8-12 weeks — patience required. Synaptic plasticity mechanism.

Schedule overview